U.S. flag

An official website of the United States government

NM_001540.5(HSPB1):c.116C>T (p.Pro39Leu) AND HSPB1-related axonal neuropathies

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jun 16, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001796974.5

Allele description [Variation Report for NM_001540.5(HSPB1):c.116C>T (p.Pro39Leu)]

NM_001540.5(HSPB1):c.116C>T (p.Pro39Leu)

Gene:
HSPB1:heat shock protein family B (small) member 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q11.23
Genomic location:
Preferred name:
NM_001540.5(HSPB1):c.116C>T (p.Pro39Leu)
HGVS:
  • NC_000007.14:g.76302828C>T
  • NG_008995.1:g.5271C>T
  • NM_001540.5:c.116C>TMANE SELECT
  • NP_001531.1:p.Pro39Leu
  • LRG_248t1:c.116C>T
  • LRG_248:g.5271C>T
  • NC_000007.13:g.75932145C>T
  • NM_001540.3:c.116C>T
Protein change:
P39L
Links:
dbSNP: rs557327165
NCBI 1000 Genomes Browser:
rs557327165
Molecular consequence:
  • NM_001540.5:c.116C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
HSPB1-related axonal neuropathies
Identifiers:

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002038568Illumina Laboratory Services, Illumina
criteria provided, single submitter

(ICSLVariantClassificationCriteria RUGD 01 April 2020)
Pathogenic
(Jun 16, 2021)
unknownclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

HSPB1 and HSPB8 in inherited neuropathies: study of an Italian cohort of dHMN and CMT2 patients.

Capponi S, Geroldi A, Fossa P, Grandis M, Ciotti P, Gulli R, Schenone A, Mandich P, Bellone E.

J Peripher Nerv Syst. 2011 Dec;16(4):287-94. doi: 10.1111/j.1529-8027.2011.00361.x.

PubMed [citation]
PMID:
22176143

Characterization of Mutants of Human Small Heat Shock Protein HspB1 Carrying Replacements in the N-Terminal Domain and Associated with Hereditary Motor Neuron Diseases.

Muranova LK, Weeks SD, Strelkov SV, Gusev NB.

PLoS One. 2015;10(5):e0126248. doi: 10.1371/journal.pone.0126248.

PubMed [citation]
PMID:
25965061
PMCID:
PMC4429025
See all PubMed Citations (5)

Details of each submission

From Illumina Laboratory Services, Illumina, SCV002038568.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

The HSPB1 c.116C>T (p.Pro39Leu) variant is a missense variant that has been reported in at least three studies, in which it was found in a heterozygous state in at least eight unrelated individuals with Charcot-Marie-Tooth disease type 2 or distal hereditary motor neuropathy (Capponi et al. 2011; Echaniz-Laguna et al. 2017; Tanabe et al. 2018). In several families, multiple affected individuals were heterozygous for the variant and in at least one individual, the variant was shown to be de novo. The p.Pro39Leu variant is reported at a frequency of 0.00001 in the European (non-Finnish) population from the Genome Aggregation Database (version 2.1.1), though this is based on one allele in a region of good sequence coverage, so the variant is presumed to be rare. Physicochemical studies of the p.Pro39Leu variant noted a decrease in phosphorylation-dependent dissociation of large oligomers and decreased chaperoning activity compared to wildtype (Muranova et al. 2015). Furthermore, the p.Pro39Leu variant was associated with mitochondrial dysfunction in motor neurons and increased vulnerability to oxidative stress (Kalmar et al. 2017). Based on the available evidence, the p.Pro39Leu variant is classified as pathogenic for HSPB1-related axonal neuropathies.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 24, 2024